Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guoshu Bi

Showing results (41-50 of 74) with videos related to

Pageof 8
Sort By:
Experimental Hematology & Oncology|April 24, 2025
Sarcosine sensitizes lung adenocarcinoma to chemotherapy by dual activation of ferroptosis via PDK4/PDHA1 signaling and NMDAR-mediated iron exportGuangyao Shan, Yunyi Bian, Shencheng Ren, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|January 24, 2024
MAFF confers vulnerability to cisplatin-based and ionizing radiation treatments by modulating ferroptosis and cell cycle progression in lung adenocarcinomaJiaqi Liang, Guoshu Bi, Yiwei Huang, et al.
Journal of Cancer Research and Therapeutics|April 27, 2026
Cone-beam CT-guided thermal ablation vs video-assisted thoracic surgery in treatment of non-small-cell lung cancer: A propensity score matching analysisZhiyuan Zheng, Guoshu Bi, Mengfei Wu, et al.
Pharmacological Research|June 15, 2023
AGRN promotes lung adenocarcinoma progression by activating Notch signaling pathway and acts as a therapeutic targetHuan Zhang, Jiaqi Liang, Tao Lu, et al.
Cancer Medicine|October 7, 2021
Integrated analysis of patients with KEAP1/NFE2L2/CUL3 mutations in lung adenocarcinomasXing Jin, Yuansheng Zheng, Zhencong Chen, et al.
Thoracic Cancer|October 1, 2021
Clinicopathological and prognostic implications of ALK rearrangement in patients with completely surgically resected lung adenocarcinomaHuan Zhang, Guangyao Shan, Benjie Cai, et al.
Heliyon|September 12, 2024
Dissection of the cell communication interactions in lung adenocarcinoma identified a prognostic model with immunotherapy efficacy assessment and a potential therapeutic candidate gene ITGB1Xing Jin, Zhengyang Hu, Jiacheng Yin, et al.
Respiratory Research|April 17, 2026
MXD4 enhances resistance to KRAS G12C-targeted therapy in lung adenocarcinoma by suppressing ACSL4-mediated ferroptosisYanjun Yi, Yidu Hu, Shencheng Ren, et al.
Nature Communications|September 2, 2025
Targeting ALDH16A1 mediated thioredoxin lysosomal degradation to enhance ferroptosis susceptibility in SMARCA4-deficient NSCLCGuoshu Bi, Jiaqi Liang, Yunyi Bian, et al.
Frontiers in Genetics|November 2, 2020
Reconstructing the Developmental Trajectories of Multiple Subtypes in Pulmonary Parenchymal Epithelial Cells by Single-Cell RNA-seqYiwei Huang, Yuansheng Zheng, Jiacheng Yin, et al.
Pageof 8

Showing results (41-50 of 74) with videos related to

Sort By:
Pageof 8
Experimental Hematology & Oncology|April 24, 2025
Sarcosine sensitizes lung adenocarcinoma to chemotherapy by dual activation of ferroptosis via PDK4/PDHA1 signaling and NMDAR-mediated iron exportGuangyao Shan, Yunyi Bian, Shencheng Ren, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|January 24, 2024
MAFF confers vulnerability to cisplatin-based and ionizing radiation treatments by modulating ferroptosis and cell cycle progression in lung adenocarcinomaJiaqi Liang, Guoshu Bi, Yiwei Huang, et al.
Journal of Cancer Research and Therapeutics|April 27, 2026
Cone-beam CT-guided thermal ablation vs video-assisted thoracic surgery in treatment of non-small-cell lung cancer: A propensity score matching analysisZhiyuan Zheng, Guoshu Bi, Mengfei Wu, et al.
Pharmacological Research|June 15, 2023
AGRN promotes lung adenocarcinoma progression by activating Notch signaling pathway and acts as a therapeutic targetHuan Zhang, Jiaqi Liang, Tao Lu, et al.
Cancer Medicine|October 7, 2021
Integrated analysis of patients with KEAP1/NFE2L2/CUL3 mutations in lung adenocarcinomasXing Jin, Yuansheng Zheng, Zhencong Chen, et al.
Thoracic Cancer|October 1, 2021
Clinicopathological and prognostic implications of ALK rearrangement in patients with completely surgically resected lung adenocarcinomaHuan Zhang, Guangyao Shan, Benjie Cai, et al.
Heliyon|September 12, 2024
Dissection of the cell communication interactions in lung adenocarcinoma identified a prognostic model with immunotherapy efficacy assessment and a potential therapeutic candidate gene ITGB1Xing Jin, Zhengyang Hu, Jiacheng Yin, et al.
Respiratory Research|April 17, 2026
MXD4 enhances resistance to KRAS G12C-targeted therapy in lung adenocarcinoma by suppressing ACSL4-mediated ferroptosisYanjun Yi, Yidu Hu, Shencheng Ren, et al.
Nature Communications|September 2, 2025
Targeting ALDH16A1 mediated thioredoxin lysosomal degradation to enhance ferroptosis susceptibility in SMARCA4-deficient NSCLCGuoshu Bi, Jiaqi Liang, Yunyi Bian, et al.
Frontiers in Genetics|November 2, 2020
Reconstructing the Developmental Trajectories of Multiple Subtypes in Pulmonary Parenchymal Epithelial Cells by Single-Cell RNA-seqYiwei Huang, Yuansheng Zheng, Jiacheng Yin, et al.
Pageof 8